Monica Raines Sells 437 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Monica Raines sold 437 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.99, for a total value of $46,754.63. Following the completion of the sale, the executive vice president owned 14,020 shares of the company’s stock, valued at approximately $1,499,999.80. The trade was a 3.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Monica Raines also recently made the following trade(s):

• On Wednesday, February 25th, Monica Raines sold 219 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total transaction of $23,073.84.

Addus HomeCare Stock Down 0.5%

Shares of NASDAQ ADUS opened at $103.53 on Friday. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $124.43. The firm’s 50-day moving average is $109.22 and its 200-day moving average is $112.95. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.92 billion, a PE ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently modified their holdings of the business. Global Retirement Partners LLC grew its position in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the period. Larson Financial Group LLC lifted its stake in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC acquired a new position in shares of Addus HomeCare in the fourth quarter valued at approximately $29,000. Arax Advisory Partners increased its position in shares of Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares in the last quarter. Finally, Private Trust Co. NA raised its holdings in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the period. Institutional investors own 95.35% of the company’s stock.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Analysts Set New Price Targets

Several analysts have commented on the stock. BMO Capital Markets started coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Truist Financial set a $135.00 target price on Addus HomeCare and gave the stock a “buy” rating in a report on Wednesday, January 7th. Finally, Barclays lowered their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.